🇺🇸 Fluticasone Furoate Inhalation Powder in United States
8 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 8
Most-reported reactions
- Dyspnoea — 2 reports (25%)
- Inappropriate Schedule Of Drug Administration — 2 reports (25%)
- Abortion Induced — 1 report (12.5%)
- Adverse Drug Reaction — 1 report (12.5%)
- Drug Intolerance — 1 report (12.5%)
- Maternal Exposure During Pregnancy — 1 report (12.5%)
Other Respiratory / Pulmonology approved in United States
Frequently asked questions
Is Fluticasone Furoate Inhalation Powder approved in United States?
Fluticasone Furoate Inhalation Powder does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Fluticasone Furoate Inhalation Powder in United States?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.